[Webinar] SPACs – Current Trends in the US and Singapore

Special Purpose Acquisition Companies (SPACs) have been one of the hottest asset classes in the United States equity market, with record numbers launched in the first quarter of 2021. The boom in SPACs has attracted a tremendous amount of attention. Last year, SGX announced that SPACs can be listed on the Mainboard of the SGX-ST.

This webinar explores how SPACs and business combinations are structured in the United States, and a comparison between the SGX SPAC listing framework and the regulations applying to SPACs and market trends in the United States.

 

$96.30
CS
Past Events

Programme:

9.15AM

Participants log in to webinar

9:30AM

Presentations on:

· SPAC overview

· Lifespan of SPAC

· Singapore SPAC framework and key considerations

10.30AM

Question & Answer

11.00AM

End of webinar

 

Speakers / Panellists

Ms Chong Ying Chiang

Counsel, Clifford Chance Singapore

Chong Ying Chiang specialises in debt and equity capital markets transactions for companies and real estate investment trusts in Singapore and across South East Asia, and is a member of the Global Financial Markets group. Ying Chiang is an active supporter of diversity and inclusion, and is a founding member of the Clifford Chance Singapore women's network.

Ying Chiang joined Clifford Chance in 2011 and is admitted in Singapore and England and Wales.

 

Mr Jeff LeMaster

Partner, Clifford Chance New York

Based in New York, Jeff is a Capital Markets partner with 15 years of experience advising on US securities laws.  Jeff has advised on several US SPAC listings and de-SPAC transactions, including advising HH&L Acquisition (SPAC sponsored by Fang Fenglei, Chairman of Chinese PE firm HOPU Investments, Kenneth Hitchner and Richard Li) on its NYSE-listed IPO.

His other notable SPAC experience includes advising:

  • a Hong Kong-based hedge fund manager with respect to a forward purchase agreement entered into in connection with the combination of United Family Healthcare with SPAC New Frontier Corporation
  • a European venture capital fund, as a minority investor in Genius Sports Group, with respect to its combination with SPAC dMY Technology Group, Inc. II
  • a Singapore-based sovereign wealth fund, as a minority investor in a proposed SPAC target
  • a US-based sponsor on an innovative SPAC funding structure
  • Bank of America, Morgan Stanley, Wells Fargo and UBS on the initial public offering of over 35 NYSE-listed, registered closed-end funds

 

Mr Matthew Warner

Counsel, Clifford Chance New York

Matthew Warner is a Counsel in the Mergers and Acquisitions group of Clifford Chance New York. Since joining the firm in 2010, Matthew has worked on both public and private mergers and acquisition in a variety of sectors.

Matthew has worked on numerous de-SPAC transactions for a variety of market participants including targets, SPACs, target shareholders, sponsors, sponsor investors, PIPE investors, other de-SPAC investors and financial advisors.  He has worked on a number of domestic de-SPAC matters but primarily focuses on de-SPACs of foreign targets seeking a listing in the US.

Matthew is a magna cum laude graduate from the University of Colorado and a graduate of the New York University School of Law (J.D. 2009), where he was a member of the NYU Journal of International Law and Politics. 

 

 

Number of Public CPD point: 1.0

Practice Area: Banking and Finance

Training Level: General

SILE Attendance Policy

Participants who wish to obtain CPD Points are reminded that they must comply strictly with the Attendance Policy set out in the CPD Guidelines. For this activity, this includes logging in at the start of the webinar and logging out at the conclusion of the webinar in the manner required by the organiser, and not being away from the entire activity for more than 15 minutes. Participants who do not comply with the Attendance Policy will not be able to obtain CPD Points for attending the activity. Please refer to  http://www.sileCPDcentre.sg for more information.

 

Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account

Recently Viewed Products